Literature DB >> 3208716

Airway permeability in rats exposed to ozone or treated with cytoskeleton-destabilizing drugs.

D K Bhalla1, S M Lavan, T T Crocker.   

Abstract

Ozone (O3) exposure of rats increases airway epithelial permeability. We hypothesized that this increased permeability may be mediated by the epithelial cell cytoskeleton. To test this hypothesis, we studied the effect of cytoskeletal disruption on the transmucosal transport of tracers from airway lumen to blood and compared the results with the effects of O3 exposure. No increase in transport occurred following disruption of microtubules by vinblastine, but disruption of microfilaments with cytochalasin D resulted in increased transport of radiolabeled tracers [99mTc- and 111In-labeled diethylenetriamine-pentacetate (DTPA) and 125I-labeled bovine serum albumin (BSA)]. In control rats, both horseradish peroxidase (HRP) and BSA, localized by cytochemistry and autoradiography, respectively, were detected on the epithelial cell surfaces and in endocytic vesicles. In rats treated with cytochalasin D or exposed to O3, the tracer molecules also penetrated the intercellular spaces, though the apical tight junctions remained devoid of the tracers. Increased numbers of endocytic vesicles containing HRP and aggregation of 125I-labeled BSA autoradiographic grains in the subepithelial region were also seen after either treatment. We conclude that destabilization of cytoskeletal elements following O3 exposure is a possible mechanism of increased transmucosal transport, which may be a combined effect of accelerated transport through both endocytic and paracellular pathways.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3208716     DOI: 10.3109/01902148809087824

Source DB:  PubMed          Journal:  Exp Lung Res        ISSN: 0190-2148            Impact factor:   2.459


  1 in total

1.  Regulation of tight junction permeability by calcium mediators and cell cytoskeleton in rabbit tracheal epithelium.

Authors:  M Bhat; D Toledo-Velasquez; L Wang; C J Malanga; J K Ma; Y Rojanasakul
Journal:  Pharm Res       Date:  1993-07       Impact factor: 4.200

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.